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Edited by Takashi GojoboriAbstract Recent studies have proposed the interesting perspec-
tive that viral gene expression is downregulated by host micro-
RNAs (miRNAs), small non-coding RNAs well known as post-
transcriptional gene regulators. We computationally predicted
human miRNA target sites within 228 human-infecting and
348 invertebrate-infecting virus genomes, and we observed that
human-infecting viruses were more likely than invertebrate-
infecting ones to be targeted by human miRNAs. We listed 62
possible human miRNA-targeted viruses from 6 families, most
of which consisted of single-stranded RNA viruses. These results
suggest that miRNAs extensively mediate antiviral defenses in
humans.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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MicroRNAs (miRNAs) are short non-coding RNAs,
approximately 22 nucleotides long, which are processed as
stem–loop precursor transcripts and hybridize incompletely
to speciﬁc target sites in mRNAs to downregulate mRNA
messages [1,2]. Recent studies have reported a large number
of computationally screened and experimentally identiﬁed
miRNAs in various animal and plant species, and a growing
number of identiﬁed miRNAs have been classiﬁed and regis-
tered in the Rfam database [3,4]. As the next step, numerous
approaches are now being taken to reveal the regulatory net-
works used bymiRNAs. Regulation bymiRNAs is complicated
because multiple and/or cooperative regulation can occur, and
the target-recognition mechanism is complex (e.g., there is
incomplete base complementation between miRNAs and their
corresponding target sites) [5]. As a result of eﬀorts to elucidateAbbreviations: miRNA, microRNA; H. sapiens, Homo sapiens;
ssRNA-positive virus, single-stranded RNA positive-strand virus;
dsDNA virus, double-stranded DNA virus
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doi:10.1016/j.febslet.2007.08.049such miRNA mechanisms and roles, many interactions be-
tween miRNAs and their target mRNAs have been identiﬁed
[6]. For the eﬃcient prediction of miRNA targets, a number
of software packages, including TargetScan [7,8], miRanda
[9,10], RNAhybrid [11], PicTar [12], and DIANA-microT
[13], have been developed and applied. In this context, our pre-
vious analysis of miRNA target sites predicted in Caenorhabdi-
tis elegans by using RNAhybrid software suggested that many
developmental genes are regulated by miRNAs [14]. Further-
more, recent miRNA target predictions in humans have dem-
onstrated that numerous genes may be regulated by miRNAs
[7,10]. The speciﬁc downregulation of mRNAs by miRNAs
is supported experimentally to some extent [15], suggesting
that miRNAs play important roles in gene regulatory net-
works.
Moreover, some miRNAs encoded by viral species, such as
the Epstein-Barr virus (EBV) and human cytomegalovirus,
have been identiﬁed by experimental studies [16,17], and one
computational analysis has suggested the existence of even
more viral miRNAs [18]. This suggests that an miRNA path-
way exists in viral species as well as in human developmental
genes, indicating that miRNA-mediated gene regulation is uni-
versal among species. Analyses of host miRNA target sites
within virus genomes have recently been launched, and mi-
RNAs have been reported to interact in several ways with viral
genes. For example, human miR-122a induces hepatitis C virus
(HCV) replication by targeting the 5 0 noncoding region of the
viral genome [19], and miR-32 restricts accumulation of the
retrovirus primate foamy virus type 1 (PFV-1) in human cells
[20]. Within PFV-1, the Tas protein, which has the ability to
suppress miRNA-directed functions in mammalian cells, has
been detected, along with miRNA-mediated viral gene regula-
tion [20]. Moreover, a computational analysis to ﬁnd miRNA
target genes in human immunodeﬁciency virus-1 (HIV-1) has
suggested that several genes in HIV-1—nef, vpr, env, and
vif—are regulated by certain types of human miRNAs [21].
A recent report provided experimental evidence that the mi-
RNA-based RNA-regulating machinery plays a key role in
the control of HIV-1 replication [22]. In order to integrate such
documented and putative viral target sites of human, mice, rat,
and chicken miRNAs, a comprehensive database named ViTa
has provided a list of host miRNA targets in viral species [23].
These ﬁndings oﬀer a glimpse into the oﬀence and defense of
viruses and their host organisms, and they implicate miRNAs
in antiviral defense in host cells. However, there is still much to
be revealed about the relationship between host miRNAs and
infecting viruses.blished by Elsevier B.V. All rights reserved.
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within the genome sequences of various viral species, we show
here the patterns interactions between human miRNAs and
human-infecting viruses. We constructed a bioinformatics
workﬂow with TargetScan software [8], and initially screened
possible human miRNA target sites within the genomes of
228 viruses that infect humans and 348 viruses that infect
invertebrate species. Comparison of these results suggested
that human miRNAs hybridize to the genomes of human-
infecting viruses rather than to the genomes of viral species
that infect invertebrates. We supported this suggestion by per-
forming the same analyses with miRNAs encoded in species
other than humans. Finally, our prediction revealed 62 viral
genomic sequences of 6 families that are the most likely to
be regulated by speciﬁc human miRNAs. The list included a
large number of viruses belonging to the Picornaviridae family,
such as echovirus and coxsackievirus. In accordance with these
results, we propose that human miRNA regulatory pathways
may defend against infections by a wide range of viruses.2. Materials and methods
2.1. Data set preparation
miRNA sequences were obtained from the miRBase website (http://
microrna.sanger.ac.uk/, accessed 2006/11/06) [3,4], a comprehensive
registry of published miRNA sequences and their annotations. We ob-
tained 470 miRNA sequences of Homo sapiens, 375 of Mus musculus,
78 of Drosophila melanogaster, 115 of C. elegans, and 119 of Arabidop-
sis thaliana in FASTA format. The viral genomic sequences were
downloaded in EMBL format from the EMBL nucleotide sequence
database (http://www.ebi.ac.uk/embl, accessed 2006/11/07) [25]. We ex-
tracted two sets of viral genomes; a ‘‘human-infecting group’’ consist-
ing of 228 viruses that infect humans, and an ‘‘invertebrate-infecting
group’’, consisting of 348 viruses that infect not humans but inverte-
brate species. The set of genomic sequences within the ‘‘human-infect-
ing group’’ was collected according to the EMBL ‘‘natural host’’
annotations and/or according to viral species name and inclusion of
the term ‘‘human’’. The set of sequences of the ‘invertebrate-infecting
group’ was composed according to the host species annotations avail-
able in the Universal Virus Database of the International Committee
on Taxonomy of Viruses (ICTVdB) (http://www.ncbi.nlm.nih.gov/
ICTVdb/,2006/11/07). Of the 576 viruses with extracted hosts, 228 were
categorized into the human-infecting group and 348 into the inverte-
brate-infecting group.
2.2. Use of two measures to evaluate viral species regulated by miRNAs
Two measures—‘‘normalized miRNA targeting scores’’ (see below)
and observed-to-expected (O/E) values—were used to screen viral gen-
ome sequences for viruses that may be regulated by human miRNAs.
For each viral genome sequence, the target sites of human-encoded
miRNAs were initially predicted with TargetScan software version
1.0 [8], and predicted pairs of miRNAs and their corresponding target
sites with binding free energies under the threshold of 20.0 kcal/mol,
a threshold value that has been used in several previous miRNA target
prediction analyses [8–10,14,21], were further screened for candidates.
We ﬁrst deﬁned the normalized miRNA targeting score of every viral
genome within the human-infecting group and the invertebrate-infect-
ing group. To do this, we calculated the sum of the free energies calcu-
lated from every pair of miRNAs and predicted target sites within the
queried viral genome; we then divided the value by the genome size and
multiplied by 100 to give the targeting score. We then screened for
those viral genomes that had higher normalized miRNA targeting
scores (higher than the cutoﬀ score of 80) and were therefore more
likely to be regulated by human miRNAs with stable interactions.
To estimate the importance of each normalized miRNA targeting
score compared with the scores obtained by randomized trials (see be-
low), the O/E values of the targeting scores were calculated for every
viral genome by the following steps. Each normalized miRNA target-
ing score derived from a set of actual human miRNA sequences wasdeﬁned as the observed value (O), whereas each normalized miRNA
targeting score derived from randomized miRNA sequences was de-
ﬁned as the expected value (E); the distribution of observed values
was divided by that of the expected values to indicate the relative
importance of the normalized miRNA targeting score calculated by
using actual miRNAs. Randomized trials were achieved by using hu-
man miRNAs shuﬄed in a way that preserved their nucleotide compo-
sitions. To generate randomized controls, the normalized miRNA
targeting score of these shuﬄed miRNAs was calculated in the same
way as described for the actual miRNAs. We repeated the randomized
experiments 100 times to calculate the average O/E values and 95%
conﬁdence intervals for candidate extraction. Also, the distributions
of O/E values were averaged for 100 experiments to compare the
virus-targeting potentials of miRNAs encoded by humans and those
encoded by other species. The 95% conﬁdence intervals for these
O/E values were also calculated and are shown in the ﬁgures as error
bars.
2.3. Determination of the best thresholds for the two measures
To compare the performance of separation of the viruses within the
human-infecting group and invertebrate-infecting group by using the
normalized miRNA targeting score and the average O/E value of the
normalized miRNA targeting score, we calculated the overall accura-
cies (Q) [26] of the two score lines, as below:
Q ¼ TPþ TN
TPþ TNþ FPþ FN
where TP (true positives) is the number of viruses within the human-
infecting group that scored above each threshold (80 for normalized
miRNA targeting score, and 1.4 for the average O/E value of the nor-
malized miRNA targeting score); TN (true negatives) is the number of
viruses in the invertebrate-infecting group that scored below the
threshold; FP (false positives) is the number of viruses in the inverte-
brate-infecting group that scored above the threshold; and FN (false
negatives) is the number of viruses in the human-infecting group that
scored below the threshold. To eﬃciently screen for human-infecting
viruses that may have been downregulated by their host miRNAs,
the best threshold of each score line was determined as the score at
which the accuracy was highest.
2.4. Prediction of human-infecting viruses downregulated by their host
miRNAs
We used four steps to extract human-encoded miRNAs targeting
viruses (Fig. 1). Using TargetScan software version 1.0 [8], we pre-
dicted the target sites of human-encoded miRNAs within the viral
genomic sequences of the human-infecting group (Step 1). We then
screened those miRNA-target pairs that had stable duplex free energy,
i.e. below the default threshold of 20.0 kcal/mol (Step 2). Then,
human-infecting virus genomes of which the normalizedmiRNA target-
ing scores were above a threshold score of 80 (Step 3) and the average
O/E values were above a threshold score of 1.4 (Step 4) were further
ﬁltered as ﬁnal candidate human-infecting viruses that may have been
regulated by human-encoding miRNAs. For details of determination
of the thresholds of the normalized miRNA targeting score and the
average O/E value, see Sections 2.3 and 3.1.
2.5. Speciﬁcity analyses of human miRNAs targeting human-infecting
viruses
To validate our hypothesis that human-infecting viruses would be
markedly more likely to be targeted by human miRNAs than viruses
that do not infect humans, we conducted the following two analyses.
First, normalized miRNA targeting scores and their O/E value distri-
butions were calculated for viral genomic sequences within the
human-infecting group and compared with those within the inverte-
brate-infecting group. Second, to analyze whether the results of the
analysis were driven speciﬁcally by human miRNAs as opposed to
invertebrate or other mammalian miRNAs, we calculated the normal-
ized miRNA binding score and O/E values for the viruses in both
human-infecting and invertebrate-infecting group, by using miRNAs
encoded in 4 species other than humans, i.e. M. musculus, D. melano-
gaster, C. elegans, and A. thaliana. These miRNAs and their target
sites have been well studied. The distributions of the scores obtained
by using these miRNAs were compared with that obtained with the
human miRNAs in both virus groups.
Fig. 1. Computational scheme for the extraction of viruses putatively
targeted by human miRNAs. Candidate human miRNA target viruses
were extracted computationally by the following four steps: miRNA
targets within each human-infecting virus were predicted by using
TargetScan software (Step 1); candidates were ﬁltered by using a
hybridization free-energy threshold of 20 (kcal/mol) (Step 2);
candidates with normalized miRNA targeting scores above a threshold
of 80 (Step 3) and average O/E values above a threshold of 1.4 were
extracted (Step 4). For details, refer to the text.
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3.1. Prediction of human-infecting viruses downregulated by
human miRNAs
We predicted energetically favorable human miRNA target
sites within the virus genomes included in the human-infecting
group and invertebrate-infecting group, according to the calcu-
lated hybridization free energy of respective pairs of human
miRNAs and their target sites by using TargetScan software
[8]. TargetScan software was the ﬁrst miRNA target-predicting
software to be developed, and it has been used eﬃciently to
predict miRNA target genes in mammals [8]. This software
searches for miRNA target sites with complete hybridization
in the miRNA seed region (2nd to 8th nucleotides in the 5 0
region of the miRNA), and calculates the free energy for each
of the predicted miRNA-target duplexes. To discard miRNA-
target pairs that, because of weak hybridization, were unlikely
to interact with each other, we adopted a free energy threshold
of 20.0 kcal/mol. miRNA-target pairs that met this criterion
were used for further target extraction.
If some human miRNAs do function speciﬁcally in defense
against human-infecting viruses, human miRNAs will have
more target sites within the genomic sequences of human-
infecting viruses than in those of invertebrate-infecting viruses.
To test this hypothesis, and to incorporate this characteristic
into our miRNA target extraction, we calculated the normal-
ized miRNA targeting scores and average O/E values for theviral sequence of each member of both the human-infecting
group and the invertebrate-infecting group. The normalized
miRNA targeting scores were calculated by dividing the total
miRNA binding free energy by the length of the correspond-
ing genomic sequence and then multiplying by -100 to elimi-
nate the eﬀect of sequence length, because longer genomic
sequences have stochastically better chances of generating
favorable miRNA binding. Thus, a high normalized miRNA
targeting score indicated that many miRNAs potentially tar-
geted multiple sites on the genomic sequence. The distribution
of the normalized miRNA targeting scores of the human-
infecting group ranged over markedly higher values did than
that of the invertebrate-infecting group (Fig. 2A). A t-test
comparing these two groups demonstrated a statistically signif-
icant diﬀerence between these two distributions (P < 0.01).
This result suggests that human miRNAs are able to bind to
more target sites on those viral genomes that infect humans
than on those that infect invertebrate species. To select candi-
date human miRNA target viruses, we screened viral genomic
sequences with normalized miRNA targeting scores higher
than 80. This threshold was taken as the point of highest over-
all accuracy (Q = 65.27) in a comparison of the scores of the
human-infecting group as a positive set with those of the inver-
tebrate-infecting group as a negative set (Fig. 2B; for details,
see Section 2.3).
In parallel, the average O/E values of normalized miRNA
targeting scores were also calculated for viral genomes in both
the human-infecting group and the invertebrate-infecting
group to produce a reliability score evaluating whether the
human-infecting viral genomes had signiﬁcantly more target
sites of actual human miRNA sequences than of randomized
miRNA sequences. We generated 100 sets of shuﬄed miRNAs
andused the sameapproaches to calculate the normalizedmiRNA
targeting scores of viral genomes within each of the random-
ized trials, which were used for the calculation of average
O/E value and 95% conﬁdence intervals. An O/E value of over
1.0 indicate the signiﬁcance of the scores originating from ac-
tual miRNAs against randomized controls. In our previous
work, we proposed and used the same method to evaluate
the prediction accuracy of miRNA target sites of C. elegans
[14]. As was the case in our evaluation of normalized miRNA
targeting scores, the distribution of average O/E values of the
human-infecting group ranged over markedly higher values
than did that of the invertebrate-infecting group, indicating
that the miRNAs tended to target viruses that infect humans
(Fig. 2A). The majority of members of the invertebrate-infect-
ing group had average O/E closer to 1.0, suggesting that their
result did not diﬀer greatly when either real or randomized
miRNA was used. In contrast, a large number of viruses in
the human-infecting group had average O/E values around
1.5, showing that human miRNA sequences were signiﬁcantly
more likely to be associated with human-infecting viruses than
were randomized miRNA sequences (P < 0.01). The threshold
of the average O/E value for miRNA target virus detection was
determined to be 1.4; this was the point at which the accuracy
(Q) took the highest value of 71.18 when the average O/E val-
ues of the human-infecting group and the invertebrate-infect-
ing group were compared (Fig. 2C). The distributions of the
normalized miRNA targeting scores and average O/E values
for the human-infecting group and invertebrate-infecting
group also suggested diﬀerences in the human miRNA recog-
nition of these 2 groups (Fig. 3A and Suppl. Fig. S1A). By
Fig. 2. Classiﬁcation of human-infecting viruses and invertebrate-infecting viruses by using two scores. (A) Average O/E value (horizontal axis) and
‘normalized miRNA targeting score’ (vertical axis) of human-infecting viruses are plotted in blue, and those of invertebrate-infecting viruses are
plotted in red. The average 95% conﬁdence intervals for average O/E values, calculated from 100 randomized trials, were 0.023 for the human-
infecting group (maximum 0.074 and minimum 0.006) and 0.025 for the invertebrate-infecting group (maximum 0.106 and minimum 0.005).
Threshold values (1.4 for average O/E value and 80 for normalized miRNA targeting score) are indicated by dotted lines. Accuracies (Q) calculated
for each normalized miRNA targeting score (B) and average O/E value (C) are shown. The threshold values are indicated by dotted lines.
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values, and their determined thresholds, from among those
viruses infecting humans we extracted 62 as possible human
miRNA targets (Table 1). Also, we listed the miRNAs that
were predicted to target human-infecting viruses, along with
their ‘‘tissue speciﬁc enrichment’’ (Heart, Connective tissue,
Embryonic tissue and cell lines, Endocrine glands and tissues,
Hematopoetic system, Kidney, Liver, Nervous system, Repro-
ductive System, and Respiratory system) analyzed within the
previous work by Landgraf et al. [24] (Suppl. Table 1).
Although the tissue speciﬁcity was observed for some miRNAs,
most of the virus targeting miRNAs express ubiquitously as
in the case of majority of human encoded miRNAs [24]. This
result suggests that miRNAs may defense against viruses by
expressing in various tissues.
3.2. Signiﬁcance of targeting of human-infecting viruses by
human miRNAs rather than by miRNAs from other species
To determine the signiﬁcance of the human miRNAs regu-
lating human-infecting viruses, normalized miRNA targeting
scores and average O/E values calculated by using human-
infecting viruses were compared with those calculated by using
invertebrate-infecting viruses (see Section 3.1). Moreover, we
analyzed of O/E values by using miRNAs encoded in 4 species
other than human, M. musculus, D. melanogaster, C. elegans,
and A. thaliana. These results were compared with those ob-
tained with human miRNAs to determine whether the distri-
butions calculated by using human miRNAs were dependent
on miRNAs encoded in humans. The distributions of the O/
E values for the human-infecting group and invertebrate-
infecting group calculated by using the miRNAs encoded in
the ﬁve diﬀerent species are shown in Fig. 3. The majority of
human-infecting viruses gave O/E values higher than 1.0 when
miRNAs from human or mouse were used for the analysis. Incontrast, the O/E values clustered around 1.0 when miRNAs
from D. melanogaster, C. elegans, and A. thaliana were used
for the same analysis, suggesting that trials with real and ran-
domized miRNAs were not markedly diﬀerent. In other words,
human or mouse miRNAs target human-infecting viruses sig-
niﬁcantly more frequently than randomized controls do. The
direct comparison of O/E values within ﬁve diﬀerent species
and possible interaction between miRNAs and human-infect-
ing viruses are summarized (Suppl. Fig. S2).
The close similarity in the distributions of O/E values calcu-
lated with human and mouse miRNAs may have been the
result of a high level of conservation of miRNA sequences
between these two species. Of the human miRNAs, 77.9%
are of the same miRNA family [4] as those of M. musculus,
whereas only 24.7% of human miRNAs share a family with
those of D. melanogaster, 11.7% with those of C. elegans,
and 1.7% with those of A. thaliana (data not shown). This
trend of conservation among the majority of known miRNAs
in humans and mice suggests that a high level of conservation
may also stand true for the unknown miRNAs of these species.
Another reason for the similar distributions of the O/E values
calculated with human and mouse miRNAs may be the rela-
tively close evolutionary distance between humans and mice,
suggesting that their virus infection mechanisms are to some
extent shared.
Similar trends were observed for both the normalized
miRNA targeting scores and the O/E values calculated for
viruses in the human-infecting group and invertebrate-infecting
groupusingmiRNAsofM.musculus,D.melanogaster,C. elegans,
and A. thaliana (Fig. 3 and Suppl. Fig. S1). These results sug-
gest that the predicted miRNA–virus pairings depend on both
the human-infecting viruses and the human miRNA se-
quences, and they support the reliability of our miRNA target
virus prediction (Fig. 3 and Suppl. Fig. S1).
Fig. 3. O/E values of human-infecting viruses and invertebrate-infecting viruses, calculated by using miRNAs from ﬁve species. Average O/E values
of human-infecting group and invertebrate-infecting group were calculated by using miRNAs encoded by ﬁve organisms: (A) Homo sapiens, (B)Mus
musculus, (C) Drosophila melanogaster, (D) Caenorhabditis elegans, and (E) Arabidopsis thaliana. Solid bars: human-infecting group; open bars:
invertebrate-infecting group. Average O/E values were calculated by taking the average value of each distribution calculated by using 100 diﬀerent
sets of shuﬄed miRNAs. Error bars indicate 95% conﬁdence intervals.
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The list of extracted candidate viruses that may be regulated
by human miRNAs includes 62 viral genomic sequences. The
higher-scoring members targeted by various human encoded
miRNAs were echovirus and papillomavirus in means of both
normalized miRNA targeting score and O/E value. RNA virus
families accounted for 66.7% (4 out of 6) of the predicted num-
ber of miRNA-targeted virus families, and all of the RNA
virus members were ssRNA positive-strand viruses (Table 1).
Moreover, ssRNA- positive virus genomes represented 56.5%
(35 of 62) of the total predicted number of miRNA target virus
genomes. In view of the fact that ssRNA-positive virus gen-
omes accounted for 43.4% (99 out of 228) of the primary dataset (i.e. before candidate extraction), this trend is unlikely to
have been the result of a pre-existing trend in the initial data
set. Therefore, ssRNA-positive viruses were extracted speciﬁ-
cally by the miRNA target-prediction scheme. These results
suggest that ssRNA-positive viruses are more strongly regu-
lated by miRNAs than are other types of viruses. Extracted
virus genomes other than ssRNA-positive ones were mainly
double-stranded DNA (dsDNA) viruses (37.1%; 23 out of
62). Interestingly, all of the extracted dsDNA viruses were
human papillomaviruses, indicating that these viruses may be
exceptionally targeted by miRNAs among dsDNA viruses,
although further analysis is necessary before we can conﬁ-
dently subscribe to this view.
Table 1
Human-infecting viruses that may be regulated by human miRNAs





(+) ssRNA virus Picornaviridae Human echovirus 11 isolate HUN-1108 7433 107.0 1.70
Human echovirus 6 7417 103.4 1.63
Human echovirus 15 strain CH 96-51 7437 101.1 1.56
Human echovirus 31 strain Caldwell 7432 94.9 1.51
Human echovirus 9 isolate DM 7453 93.1 1.43
Human echovirus 27 strain Bacon 7412 92.9 1.45
Human echovirus 16 strain Harrington 7437 91.2 1.41
Human echovirus 3 strain Morrisey 7428 90.2 1.44
Human echovirus 33 strain Toluca-3 7394 89.7 1.40
Human echovirus 17 strain CHHE-29 7416 89.1 1.41
Human echovirus 30 7440 88.8 1.41
Human echovirus 30 strain Bastianni 7445 88.3 1.41
Human coxsackievirus B3 7399 100.2 1.56
Human coxsackievirus A16 7413 95.1 1.49
Human coxsackievirus B5 7402 94.7 1.55
Human coxsackievirus A24 7461 94.3 1.60
Human coxsackievirus B6 7393 93.5 1.50
Human coxsackievirus B2 7403 93.1 1.44
Human coxsackievirus A18 7460 91.2 1.58
Human coxsackievirus B4 7395 90.4 1.42
Human coxsackievirus B4 strain E2 7397 89.4 1.43
Human coxsackievirus A21 (strain Coe) 7401 83.1 1.45
Human poliovirus 1 7441 95.5 1.59
Human poliovirus 1 Mahoney 7440 92.2 1.56
Human poliovirus 2 7440 88.0 1.42
Human poliovirus 3 7432 85.1 1.40
Enterovirus 95 strain CIV03-10361 7442 89.7 1.42
Human enterovirus 90 isolate F950027 7438 86.3 1.47
Human rhinovirus 14 7212 80.2 1.81
Caliciviridae Human calicivirus NLV/GII/Langen1061/2002/DE 7556 102.0 1.43
Snow Mountain virus 7537 101.6 1.44
Retroviridae Simian-Human immunodeﬁciency virus 10006 83.5 1.59
Astroviridae Human astrovirus 6828 83.9 1.61
Human astrovirus 4 6723 81.8 1.52
Human astrovirus 1 6771 81.3 1.47
dsDNA virus Papillomaviridae Human papillomavirus type 2a 7860 106.6 1.65
Human papillomavirus type 57b 7868 103.7 1.50
Human papillomavirus type 29 7916 103.5 1.76
Human papillomavirus type 106 8035 101.6 1.63
Human papillomavirus type 27 7823 101.2 1.53
Human papillomavirus type 27b 7831 99.5 1.51
Human papillomavirus type 57 7861 98.5 1.43
Human papillomavirus type 94 7881 97.8 1.62
Human papillomavirus type 3 7820 92.5 1.61
Human papillomavirus type 28 7959 92.2 1.55
Human papillomavirus – cand87 7998 91.8 1.60
Human papillomavirus type 61 7989 90.3 1.50
Human papillomavirus – 81 8070 89.7 1.60
Human papillomavirus type 10 7919 89.6 1.50
Human papillomavirus – cand62 8092 88.7 1.48
Human papillomavirus type 84 7948 88.5 1.47
Human papillomavirus type 101 7259 88.0 1.69
Human papillomavirus – cand86 7983 87.5 1.47
Human papillomavirus type 55 7822 86.3 1.86
Human papillomavirus type 102 8078 84.6 1.44
Human papillomavirus – 83 8104 83.6 1.42
Human papillomavirus type 8 7654 82.6 1.63
Human papillomavirus type 40 7909 81.2 1.52
ssDNA virus Parvovirinae Human parvovirus B19 5594 86.7 1.65
Human parvovirus 4 5268 85.9 1.52
Human bocavirus WLL-1 5297 82.8 1.67
Human bocavirus isolate st2 5299 82.5 1.67
Candidate human miRNA target viruses are listed along with their virus types, virus family names, lengths of genomic sequences, normalized
miRNA targeting scores, and average O/E values. The normalized miRNA targeting score was calculated by dividing the total free energy by the
length of the viral genomic sequence and multiplying by 100.
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replication [27]. This virus is one of the leading causes of acute
febrile illness and aseptic meningitis, especially in young
children [27]. Predicted miRNA target sites were distributed
within both coding and non-coding regions, although the
distribution of target sites was relatively intense within the
regions encoding the capsid proteins 1B (VP2) and 1C (VP3)
(data not shown). These proteins, together with VP1 and
VP4, form a closed capsid enclosing the viral positive-strand
RNA genome.
Although the majority of candidates were RNA viruses,
three types of DNA viruses were also included on the list.
Most of the candidate viruses from this group were human
papillomaviruses (23 out of 27). These viruses have circular
double-stranded DNA genomes close to 8 kb in size, and they
are known to cause cervical cancer and epithelial tumors [28].
The miRNA target sites on these viruses were distributed
equally within both coding and non-coding regions (data not
shown). Human papillomaviruses have persistent life strate-
gies, i.e. they have biological characteristics that give them per-
sistence in individual hosts and genetic stability [29]. The
predicted targeting miRNAs for the viruses in each family
are listed along with the number of target sites in Supplemen-
tary Table 1. Two known miRNA target viruses, HCV [19] and
PFV-1 [20], were not extracted as candidate miRNA target
viruses in our search. This was because their genomic se-
quences were not included within our primary dataset. How-
ever, since both HCV and PFV-1 are ssRNA positive-strand
viruses, the fact that the majority of our predicted human
miRNA target viruses were ssRNA positive-strand viruses
supports the likelihood that these viruses will be classed as
predicted targets of miRNAs when their sequences become
available.
In conclusion, our analyses suggest that human miRNAs
regulate various human-infecting viruses via binding and down
regulation of their target genes as a form of antiviral defense,
as shown by the stronger miRNA binding and higher signiﬁ-
cance against randomized controls and non-human encoded
miRNA controls. Therefore, we showed that there was
speciﬁcity of binding between human-infecting viruses and
human-encoded miRNAs. We extracted 62 viral genomic se-
quences from 6 diﬀerent virus families as candidate miRNA
targets. The extracted candidates were mainly RNA viruses,
suggesting that RNA viruses are more likely to be targets of
human miRNAs any other types of viruses. From these results,
we believe that human miRNAs function as antiviral defense
mechanisms against a wide range of human-infecting viruses.
Moreover, these ﬁndings would provide the experimentalists
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found, in the online version, at doi:10.1016/j.febslet.2007.08.
049.References
[1] Ambros, V. (2001) microRNAs: tiny regulators with great
potential. Cell 107, 823–826.
[2] Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mecha-
nism, and function. Cell 116, 281–297.
[3] Griﬃths-Jones, S. (2004) The microRNA Registry. Nucleic Acids
Res. 32, D109–D111.
[4] Griﬃths-Jones, S., Moxon, S., Marshall, M., Khanna, A., Eddy,
S.R. and Bateman, A. (2005) Rfam: annotating non-coding
RNAs in complete genomes. Nucleic Acids Res. 33, D121–D124.
[5] Rajewsky, N. (2006) microRNA target predictions in animals.
Nat Genet. 38 (Suppl.), S8–S13.
[6] Bentwich, I. (2005) Prediction and validation of microRNAs and
their targets. FEBS Lett. 579, 5904–5910.
[7] Lewis, B.P., Burge, C.B. and Bartel, D.P. (2005) Conserved seed
pairing, often ﬂanked by adenosines, indicates that thousands of
human genes are microRNA targets. Cell 120, 15–20.
[8] Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. and
Burge, C.B. (2003) Prediction of mammalian microRNA targets.
Cell 115, 787–798.
[9] Enright, A.J., John, B., Gaul, U., Tuschl, T., Sander, C. and
Marks, D.S. (2003) MicroRNA targets in Drosophila. Genome
Biol. 5, R1.
[10] John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C. and
Marks,D.S. (2004)HumanMicroRNA targets. PLoSBiol. 2, e363.
[11] Rehmsmeier, M., Steﬀen, P., Hochsmann, M. and Giegerich, R.
(2004) Fast and eﬀective prediction of microRNA/target duplexes.
RNA 10, 1507–1517.
[12] Krek, A. et al. (2005) Combinatorial microRNA target predic-
tions. Nat Genet. 37, 495–500.
[13] Kiriakidou, M., Nelson, P.T., Kouranov, A., Fitziev, P., Bou-
yioukos, C., Mourelatos, Z. and Hatzigeorgiou, A. (2004) A
combined computational-experimental approach predicts human
microRNA targets. Genes Dev. 18, 1165–1178.
[14] Watanabe, Y., Yachie, N., Numata, K., Saito, R., Kanai, A. and
Tomita, M. (2006) Computational analysis of microRNA targets
in Caenorhabditis elegans. Gene 365, 2–10.
[15] Lim, L.P. et al. (2005) Microarray analysis shows that some
microRNAs downregulate large numbers of target mRNAs.
Nature 433, 769–773.
[16] Pfeﬀer, S. et al. (2004) Identiﬁcation of virus-encoded micro-
RNAs. Science 304, 734–736.
[17] Pfeﬀer, S. et al. (2005) Identiﬁcation of microRNAs of the
herpesvirus family. Nat Methods 2, 269–276.
[18] Bennasser, Y. and Jeang, K.T. (2006) HIV-1 Tat interaction with
Dicer: requirement for RNA. Retrovirology 3, 95.
[19] Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M. and
Sarnow, P. (2005) Modulation of hepatitis C virus RNA
abundance by a liver-speciﬁc MicroRNA. Science 309, 1577–1581.
[20] Lecellier, C.H., Dunoyer, P., Arar, K., Lehmann-Che, J.,
Eyquem, S., Himber, C., Saib, A. and Voinnet, O. (2005) A
cellular microRNA mediates antiviral defense in human cells.
Science 308, 557–560.
[21] Hariharan, M., Scaria, V., Pillai, B. and Brahmachari, S.K. (2005)
Targets for human encoded microRNAs in HIV genes. Biochem.
Biophys. Res. Commun. 337, 1214–1218.
[22] Triboulet, R. et al. (2007) Suppression of microRNA-silencing
pathway by HIV-1 during virus replication. Science 315, 1579–
1582.
[23] Hsu, P.W., Lin, L.Z., Hsu, S.D., Hsu, J.B. and Huang, H.D.
(2007) ViTa: prediction of host microRNAs targets on viruses.
Nucleic Acids Res. 35, D381–D385.
[24] Landgraf, P. et al. (2007) A mammalian microRNA expression
atlas based on small RNA library sequencing. Cell 129, 1401–1414.
[25] Kulikova, T. et al. (2007) EMBL nucleotide sequence database in
2006. Nucleic Acids Res. 35, D16–D20.
4610 Y. Watanabe et al. / FEBS Letters 581 (2007) 4603–4610[26] Baldi, P., Brunak, S., Chauvin, Y., Andersen, C.A. and Nielsen,
H. (2000) Assessing the accuracy of prediction algorithms for
classiﬁcation: an overview. Bioinformatics 16, 412–424.
[27] Modlin, J.F. (1986) Perinatal echovirus infection: insights from a
literature review of 61 cases of serious infection and 16 outbreaks
in nurseries. Rev. Infect. Dis. 8, 918–926.[28] de Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.U. and
zur Hausen, H. (2004) Classiﬁcation of papillomaviruses. Virol-
ogy 324, 17–27.
[29] Villarreal, L.P. (2005) Viruses and the Evolution of Life,
American Society for Microbiology Press.
